Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: A pilot study

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2183-2188

  Wong, Ivy H N ^a   Chan, Andrew T ^b   Johnson, Philip J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; MESSENGER RNA; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; MALE; METASTASIS; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SCHOOL CHILD; TUMOR CELL;

ADOLESCENT; ADULT; BLOTTING, SOUTHERN; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHILD; COLLAGEN; FEMALE; GENETIC MARKERS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; OSTEOSARCOMA; PILOT PROJECTS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIALOGLYCOPROTEINS; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0034096259     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Wadayama, B., Toguchida, J., Shimizu, T., Ishizaki, K., Sasaki, M. S., Kotoura, Y., and Yamamuro, T. Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res., 54: 3042-3048, 1994.
2. McIntyre, J. F., Smith-Sorensen, B., Friend, S. H., Kassell, J., Borresen, A. L., Yan, Y. X., Russo, C., Sato, J., Barbier, N., Miser, J., Malkin, D., and Gebhardt, M. C. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma. J. Clin. Oncol., 12: 925-930, 1994.
3. Ladanyi, M., Cha, C., Lewis, R., Jhanwar, S. C., Huvos, A. G., and Healey, J. H. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res., 53: 16-18, 1993.
4. Ladanyi, M., Park, C. K., Lewis, R., Jhanwar, S. C., Healey, J. H., and Huvos, A. G. Sporadic amplification of the MYC gene in human osteosarcomas. Diagn. Mol. Pathol., 2: 163-167, 1993.
5. Onda, M., Matsuda, S., Higaki, S., Iijima, T., Fukushima, J., Yokokura, A., Kojima, T., Horiuchi, H., Kurokawa, T., and Yamamoto, T. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma. Cancer (Phila.), 77: 71-78, 1996.
6. Meyers, P. A., Heller, G., Healey, J. H., Huvos, A., Applewhite, A., Sun, M., and LaQuaglia, M. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J. Clin. Oncol., 11: 449-453, 1993.
7. Meyers, P. A., and Gorlick, R. Osteosarcoma. Pediatr. Clin. North Am., 44. 973-989, 1997.
8. Wong, I. H. N., Lau, W. Y., Leung, T., Yeo, W., and Johnson, P. J. Hematogenous dissemination of hepatocytes and tumor cells following surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin. Cancer Res., 5: 4021-4027, 1999.
9. Wong, I. H. N., Ng, M. H. L., Huang, D. P., and Lee, J. C. K. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all the morphologic subtypes: potential prognostic implications. Blood, 95: 1942-1949, 2000.
10. Wong, I. H. N., Lo, Y. M. D., Zhang, J., Liew, C. T., Ng, M. H. L., Wong, N., Lai, P. B. S., Lau, W. Y., Hjelm, N. M., and Johnson, P. J. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res., 59: 71-73, 1999.
11. Hatano, H., Tokunaga, K., Ogose, A., Hotta, T., Yamagiwa, H., Hayami, T., Endo, N., and Takahashi, H. E. Origin of bone-forming cells in human osteosarcomas transplanted into nude mice - which cells produce bone, human or mouse? J. Pathol., 185: 204-211, 1998.
12. Gundberg, C. M., Hauschka, P. V., Lian, J. B., and Gallop, P. M. Osteocalcin: isolation, characterization, and detection. Methods Enzymol., 107: 516-544, 1984.
13. Termine, J. D., Kleinman, H. K., Whitson, S. W., Conn, K. M., McGarvey, M. L., and Martin, G. R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell, 26: 99-105, 1981.
14. Nomura, S., Wills, A. J., Edwards, D. R., Heath, J. K., and Hogan, B. L. M. Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol., 106: 441-450, 1988.
15. Grigoriadis, A. E., Schellander, K., Wang, Z. Q., and Wagner, E. F. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol., 122: 685-701, 1993.
16. Gerstenfeld, L. C., Uporova, T., Schmidt, J., Strauss, P. G., Shih, S. D., Huang, L. F., Gundberg, C., Mizuno, S., and Glowacki, J. Osteogenic potential of murine osteosarcoma cells: comparison of bone-specific gene expression in in vitro and in vivo conditions. Lab. Invest., 74: 895-906, 1996.
17. Lane, T. F., and Sage, E. H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J., 8: 163-173, 1994.
18. Le Bail, B., Faouzi, S., Boussarie, L., Guirouilh, J., Blanc, J. F., Carles, J., Bioulac-Sage, P., Balabaud, C., and Rosenbaum, J. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma. J. Pathol., 189: 46-52, 1999.
19. Hirota, S., Ito, A., Nagoshi, J., Takeda, M., Kurata, A., Takatsuka, Y., Kohri, K., Nomura, S., and Kitamura, Y. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers: possible involvement of osteopontin in development of calcifying foci. Lab. Invest., 72: 64-69, 1995.
20. Ledda, F., Bravo, A. I., Adris, S., Bover, L., Mordoh, J., and Podhajcer, O. L. The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J. Invest. Dermatol., 108: 210-214, 1997.
21. Bellahcene, A., and Castronovo, V. Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am. J. Pathol., 146: 95-100, 1995.
22. Porter, P. L., Sage, E. H., Lane, T. F., Funk, S. E., and Gown, A. M. Distribution of SPARC in normal and neoplastic human tissue. J. Histochem. Cytochem., 43: 791-800, 1995.
23. Mendis, D. B., Ivy, G. O., and Brown, I. R. SPARC/osteonectin mRNA is induced in blood vessels following injury to the adult rat cerebral cortex. Neurochem. Res., 23: 1117-1123, 1998.
24. Prols, F., Loser, B., and Marx, M. Differential expression of osteopontin, PC4, and CEC5, a novel mRNA species, during in vitro angiogenesis. Exp. Cell Res., 239: 1-10, 1998.
25. Reinholt, F. P., Hultenby, K., Oldberg, A., and Heinegard, D. Osteopontin - a possible anchor of osteoclasts to bone. Proc. Natl. Acad. Sci. USA, 87: 4473-4475, 1990.
26. Sodek, J., Chen, J., Nagata, T., Kasugai, S., Todescan, R., Jr., Li, I. W., and Kim, R. H. Regulation of osteopontin expression in osteoblasts. Ann. NY Acad. Sci., 760: 223-241, 1995.
27. Sharp, J. A., Sung, V., Slavin, J., Thompson, E. W., and Henderson, M. A. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. Lab. Invest., 79: 869-877, 1999.
28. Gillespie, M. T., Thomas, R. J., Pu, Z. Y., Zhou, H., Martin, T. J., and Findlay, D. M. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers. Int. J. Cancer, 73: 812-815, 1997.
29. Brown, L. F., Papadopoulos-Sergiou, A., Berse, B., Manseau, E. J., Tognazzi, K., Perruzzi, C. A., Dvorak, H. F., and Senger, D. R. Osteopontin expression and distribution in human carcinomas. Am. J. Pathol., 145: 610-623, 1994.
30. Xuan, J. W., Hota, C., Shigeyama, Y., D'Errico, J. A., Somerman, M. J., and Chambers, A. F. Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions. J. Cell. Biochem., 57: 680-690, 1995.
31. Senger, D. R., Perruzzi, C. A., Gracey, C. F., Papadopoulos, A., and Tenen, D. G. Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res., 48: 5770-5774, 1988.
32. Crawford, H. C., Matrisian, L. M., and Liaw, L. Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. Cancer Res., 58: 5206-5215, 1998.
33. Chelly, J., Concordet, J. P., Kaplan, J. C., and Kahn, A. Illegitimate transcription: transcription of any gene in any cell type. Proc. Natl. Acad. Sci. USA, 86: 2617-2621, 1989.
34. Wong, I. H. N., Leung, T., Ho, S., Lau, W. Y., Chan, M., and Johnson, P. J. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Br. J. Cancer, 76: 628-633, 1997.
35. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
36. Wong, I. H. N., Ng, M. H. L., Lee, J. C. K., Lo, K. W., Chung, Y. F., and Huang, D. P. Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation. Br. J. Haematol.. 103: 168-175, 1998.
37. Thiede, M. A., Smock, S. L., Petersen, D. N., Grasser, W. A., Thompson, D. D., and Nishimoto, S. K. Presence of messenger ribonucleic acid encoding osteocalcin, a marker of bone turnover, in bone marrow megakaryocytes and peripheral blood platelets. Endocrinology, 135: 929-937, 1994.
38. Fleet, J. C., and Hock, J. M. Identification of osteocalcin mRNA in nonosteoid tissue of rats and humans by reverse transcription-polymerase chain reaction. J. Bone Miner. Res., 9: 1565-1573, 1994.
39. Noda, M., and Rodan, G. A. Type β transforming growth factor (TGF β) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblastic rat osteosarcoma cells. J. Cell. Physiol., 133: 426-437, 1987.
40. Wrana, J. L., Overall, C. M., and Sodek, J. Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β: Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen. Eur. J. Biochem., 197: 519-528, 1991.
41. Pollack, S. B., Linnemeyer, P. A., and Gill, S. Induction of osteopontin mRNA expression during activation of murine NK cells. J. Leukoc. Biol., 55: 398-400, 1994.
42. Galera, P., Musso, M., Ducy, P., and Karsenty, G. c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin. Proc. Natl. Acad. Sci. USA, 91: 9372-9376, 1994.
43. Sandberg, M., Autio-Harmainen, H., and Vuorio, E. Localization of the expression of types I, III, and IV collagen, TGF-β 1 and c-fos genes in developing human calvarial bones. Dev. Biol., 130: 324-334, 1988.